Netherlands

Scinvivo secures €4.7M to advance Cancer Diagnostics Technology
Scinvivo, an Eindhoven-based medtech startup, has successfully raised €4.7M in funding to enhance its innovative cancer diagnostics technology. The investment round was led by Santec OIS Corporation and The NLC Health Impact fund, with additional support from current shareholders and an "Innovatiekrediet" (Innovation credit) loan from the Netherlands Enterprise Agency (RvO).
Scinvivo, an Eindhoven-based medtech startup, has successfully raised €4.7M in funding to enhance its innovative cancer diagnostics technology. The investment round was led by Santec OIS Corporation and The NLC Health Impact fund, with additional support from current shareholders and an "Innovatiekrediet" (Innovation credit) loan from the Netherlands Enterprise Agency

The best Articles in our Network

Previous
Next